Skip to main content
NCBI home page
Tobacco Control logoLink to Tobacco Control
. 2004 Dec;13(4):362–369. doi: 10.1136/tc.2004.007914

A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes

J Dunsby 1, L Bero 1
PMCID: PMC1747963  PMID: 15564619

Abstract

Background: Defining harm reduction and regulating potentially reduced exposure products (PREPs), including low nicotine products, are key issues in tobacco control policy. The US Congress has been considering legislation authorising the Food and Drug Administration (FDA) to regulate tobacco products.

Objective: To investigate tobacco industry perceptions, interests, motivations, and knowledge regarding the marketability of low nicotine tobacco products.

Methods: Qualitative analysis of internal tobacco industry documents identified in the Legacy Tobacco Documents Library between February 2002 and June 2004. Search terms included low-, no-, reduced-nicotine; denicotinization; low-, reduced- alkaloids; Next; de-nic; and key names of people, organisations, projects, and their common abbreviations and acronyms.

Results: The tobacco industry has made repeated efforts to develop low nicotine cigarettes. Reasons for doing so include consumer appeal and economic importance in a highly competitive cigarette market for "healthier" products. The industry considered the development of a new "denic" market segment a critical challenge.

Conclusions: The tobacco industry exploits consumer misunderstanding of the health effects of nicotine in development and marketing efforts. The industry has risked the development of a less addictive product to expand the market reach of tobacco products based on perceived health benefits and appeal to quitters.

Full Text

The Full Text of this article is available as a PDF (98.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benowitz N. L., Gourlay S. G. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997 Jun;29(7):1422–1431. doi: 10.1016/s0735-1097(97)00079-x. [DOI] [PubMed] [Google Scholar]
  2. Benowitz N. L., Henningfield J. E. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994 Jul 14;331(2):123–125. doi: 10.1056/NEJM199407143310212. [DOI] [PubMed] [Google Scholar]
  3. Benowitz Neal L. Smoking less as a treatment goal for those who cannot stop smoking. Am J Med. 2004 Feb 1;116(3):203–205. doi: 10.1016/j.amjmed.2003.11.009. [DOI] [PubMed] [Google Scholar]
  4. Bero Lisa. Implications of the tobacco industry documents for public health and policy. Annu Rev Public Health. 2001 Nov 6;24:267–288. doi: 10.1146/annurev.publhealth.24.100901.140813. [DOI] [PubMed] [Google Scholar]
  5. Cummings K. M., Morley C. P., Hyland A. Failed promises of the cigarette industry and its effect on consumer misperceptions about the health risks of smoking. Tob Control. 2002 Mar;11 (Suppl 1):I110–I117. doi: 10.1136/tc.11.suppl_1.i110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Douglas C. E. Taking aim at the bull's-eye: the nicotine in tobacco products. Tob Control. 1998 Autumn;7(3):215–218. doi: 10.1136/tc.7.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Farone W. A. Harm reduction: 25 years later. Tob Control. 2002 Dec;11(4):287–288. doi: 10.1136/tc.11.4.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fox Brion J., Cohen Joanna E. Tobacco harm reduction: a call to address the ethical dilemmas. Nicotine Tob Res. 2002;4 (Suppl 2):S81–S87. doi: 10.1080/1462220021000032861. [DOI] [PubMed] [Google Scholar]
  9. Hecht Stephen S., Murphy Sharon E., Carmella Steven G., Zimmerman Cheryl L., Losey London, Kramarczuk Irene, Roe Mikel R., Puumala Susan S., Li Y. Shelby, Le Chap. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. J Natl Cancer Inst. 2004 Jan 21;96(2):107–115. doi: 10.1093/jnci/djh016. [DOI] [PubMed] [Google Scholar]
  10. Henningfield J. E., Benowitz N. L., Slade J., Houston T. P., Davis R. M., Deitchman S. D. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association. Tob Control. 1998 Autumn;7(3):281–293. doi: 10.1136/tc.7.3.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol. 2001 Jul;14(7):767–790. doi: 10.1021/tx000260u. [DOI] [PubMed] [Google Scholar]
  12. Kozlowski L. T., Goldberg M. E., Yost B. A., White E. L., Sweeney C. T., Pillitteri J. L. Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking. Am J Prev Med. 1998 Jul;15(1):9–16. doi: 10.1016/s0749-3797(98)00004-x. [DOI] [PubMed] [Google Scholar]
  13. Malone R. E., Balbach E. D. Tobacco industry documents: treasure trove or quagmire? Tob Control. 2000 Sep;9(3):334–338. doi: 10.1136/tc.9.3.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pierce John P. Harm reduction or harm maintenance? Nicotine Tob Res. 2002;4 (Suppl 2):S53–S54. doi: 10.1080/1462220021000032834. [DOI] [PubMed] [Google Scholar]
  15. Pollay R. W., Dewhirst T. The dark side of marketing seemingly "Light" cigarettes: successful images and failed fact. Tob Control. 2002 Mar;11 (Suppl 1):I18–I31. doi: 10.1136/tc.11.suppl_1.i18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shamasunder Bhavna, Bero Lisa. Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA. 2002 Aug 14;288(6):738–744. doi: 10.1001/jama.288.6.738. [DOI] [PubMed] [Google Scholar]
  17. Shiffman Saul, Gitchell Joe G., Warner Kenneth E., Slade John, Henningfield Jack E., Pinney John M. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Nicotine Tob Res. 2002;4 (Suppl 2):S113–S129. doi: 10.1080/1462220021000032717. [DOI] [PubMed] [Google Scholar]
  18. Slade J., Bero L. A., Hanauer P., Barnes D. E., Glantz S. A. Nicotine and addiction. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):225–233. [PubMed] [Google Scholar]
  19. Warner K. E., Slade J., Sweanor D. T. The emerging market for long-term nicotine maintenance. JAMA. 1997 Oct 1;278(13):1087–1092. [PubMed] [Google Scholar]
  20. Warner Kenneth E. Tobacco harm reduction: promise and perils. Nicotine Tob Res. 2002;4 (Suppl 2):S61–S71. doi: 10.1080/1462220021000032825. [DOI] [PubMed] [Google Scholar]
  21. Wayne G. Ferris, Connolly G. N. How cigarette design can affect youth initiation into smoking: Camel cigarettes 1983-93. Tob Control. 2002 Mar;11 (Suppl 1):I32–I39. doi: 10.1136/tc.11.suppl_1.i32. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES